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The potential value of the Y chromosome for forensic applications has been recognized 
for some time with the current work dedicated to Short Tandem Repeat analysis and Single 
Nucleotide Polymorphism (SNP) discovery.  This study examined the ability of two different 
SNP analysis methods to determine if they could be utilized in forensic applications and 
ultimately be developed into an established system for Y chromosome SNP analysis.  
This study examined two principle SNP analysis systems: single base extension and 
Pyrosequencing.  Pyrosequencing was determined to be superior to single base extension, due to 
the wealth of information provided with sequencing and the flexibility of designing primers for 
analysis.  Using Pyrosequencing, 50 Y chromosome loci were examined and the minimum loci 
required for maximum diversity for the development of a Y chromosome SNP analysis system 
were chosen. Thirteen loci were selected based on their ability to discriminate 60 different 
individuals from three different racial groups into 15 different haplogroups. The Y chromosome 
SNP analysis system developed utilized nested PCR for the amplification of all 13 loci. Then 
they were sequenced as groups, ranging from one to three loci, in a single reaction.  
The Y chromosome SNP analysis system developed here has the potential for forensic 
application since it has shown to be successful in the analysis of blood, buccal swabs, semen, and 
saliva, works with as little as 5 pg of starting DNA material, and will amplify only male DNA in 
the presence of male/female mixtures in which the female portion of the sample overwhelmed 
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CHAPTER 1. INTRODUCTION 
 
The Y chromosome is the human male sex-determining chromosome and contains 
approximately 50 million base pairs [1]. The Y chromosome is divided into three distinct 
sections: the pseudoautosomals regions, the euchromatin and the heterochromatin.  The 
pseudoautosomals regions make up 5% of the total genomic content and are located at the distal 
ends of each arm of the Y chromosome (PAR1 and PAR2).  The pseudoautosomals regions have 
99% homology with the X chromosome and are responsible for the Y chromosomes correct 
pairing with the X chromosome during meosis [2].  The remaining 95% of the Y chromosome 
contains approximately 24 Mb of euchromatin and 30 Mb of heterochromatin all within the non-
recombining region (NRY).  The heterochromatin contains areas of condensed inert genetic 
material while the euchromatin contains all the functional genes, most having to do with male 
sexuality and fertility [3].  The NRY as the name implies, does not recombine during meiosis and 
is therefore passed paternally from father to son without alterations, baring any rare mutation. 
 The paternal heritage of an unaltered NRY has shown a myriad of possible applications 
including population migration/ethnicity [4, 5], instances of questioned paternity [6], and 
forensic applications.  Forensically, the Y chromosome is valuable in instances of male/female 
mixtures, especially when the female portion greatly overwhelms the male portion of the 
mixture. Such an instance could be achieved with the deposit of semen by an azoospermic or 
oligospermic male, oral sodomy where only trace amounts of male buccal epithelial cells may be 
present, or the normal post-coital degradative and sample loss that occurs with the passage of 
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time [7].  Due to the Y chromosome’s non homologous nature with the X chromosome, Y 
chromosome analysis could eliminate the time-consuming and often inefficient differential 
extraction procedure.  Y chromosome analysis is also forensically useful in instances of disaster 
identification or missing persons, by requiring the analysis of only a male relative to the person 
in question.  It has even been suggested that this mode of inheritance could enable a particular Y 
chromosome analysis recovered at a crime scene to be linked with a surname although the 
confounding effects of non-paternity and multiple independent origins of surnames would need 
to be taken into account [7].  
 Analysis of the Y chromosome can be accomplished through examination of one of the 
two major types of genetic variants: tandem repeats (such as short tandem repeats (STRs)) or 
single nucleotide polymorphisms (SNPs).  SNPs are the smallest unit of mutation which allows 
for their analysis in degraded samples, but have a low number of alleles present at each mutation 
point compared with STRs.  To overcome this drawback, a larger number of SNPs need to be 
examined to get a discriminating potential similar to a minimal number of STRs.  This is not a 
problem due to the abundance of SNPs located within the genome (over 1.42 million, and more 
than 4000 on the Y chromosome alone [8]) and the potential for automation with numerous 
analysis techniques.   
 With the emergence of SNPs and their overwhelming number, many methods have been 
established for their identification.  Various methods utilize allele specific oligonucleotide (ASO) 
hybridization to differentiate between allele variants.  A drawback to this technique is the 
propensity for mispriming which can cause false positive results [9].  Another common SNP 
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analysis technique is single base extension.  This technique utilizes a primer that binds to the 
template DNA one base away from the SNP of interest.  DNA polymerase is then used to extend 
the primer one nucleotide, complimentary to the SNP located in the template.  Once the primer is 
extended multiple analysis techniques are used to determine which of the four dNTPs 
(Adenosine, Cytosine, Guanine, or Thiamine) was incorporated.   
 One method of single base extension currently available is the ABI Prism SNaPshot 
ddNTP Primer Extension.  SNaPshot is based on the dideoxy single nucleotide extension of an 
unlabeled oligonucleotide primer.  An oligonucleotide primer binds to a complimentary DNA 
template one nucleotide (5’) to an SNP of interest. In the presence of Amplitaq DNA polymerase 
and fluorescently labeled ddNTPs, the primer is extended one nucleotide by the addition of one 
of the fluorescently labeled ddNTPs [10].  To determine which base was incorporated and 
subsequently to identify the SNP of interest the extended products are run through an ABI Prism 
310 Genetic Analyzer.  The base that was incorporated can be determined by the florescent 
signal observed, because each nucleotide is labeled with a different florescent dye (Table 1). For 
example, a green florescence signal corresponding to the elution time when the primer plus one 
sized nucleotide exits the column indicates that the oligonuclotide primer was extended using an 
Adenosine nucleotide.  Therefore the template DNA had a Thymine nucleotide 3’ to the primer 
binding site. This technique can be problematic if the DNA sequence adjacent to the SNP is not 
conducive for primer design or binding.  Primers which have complimentary regions between 
their 3’ end and internal sequences can form primer dimmers or hairpins and ultimately lead to 
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The most informative SNP analysis technique is sequencing.  Sequencing the DNA 
around a SNP provides sequence contex for accurate genotype conformation. Since sequencing 
the DNA can begin at any site there are more options in choice for the sequencing primer, while 
also leading to easier elimination of false positives from primer interactions.  Conventional 
sequencing utilizes dideoxy chain termination methodology, but has limitations in both 
throughput and cost for SNP analysis [12].  An alternate method of DNA sequencing is 
pyrosequencing.  Pyrosequencing is a sequencing by synthesis technique which provides for an 
accurate and consistent analysis of DNA sequences [13].  This methodology sequences DNA by 
monitoring the release of pyrophosphate during the incorporation of known nucleotides in DNA 
synthesis.   
Pyrosequencing begins by hybridizing a sequencing primer to a PCR amplified ssDNA 
template.  This hybridized template/primer combination is then mixed with an enzyme cocktail 
containing DNA polymerase, ATP sulfurylase, luciferase, and apyrase, as well as a substrate mix 
of adenosine 5’ phosphosulfate (APS) and luciferin.  Once the template/primer, enzymes and 
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substrates are mixed, one of four deoxynucleotide triphosphates (dNTP) is added to the reaction.  
If the added nucleotide is complimentary to the template nucleotide, 3’ to the extension primer, 
then DNA polymerase will incorporate the dNTP into the extension primer DNA strand.  This 
incorporation causes the release of pyrophosphate (PPi) in amounts proportional to the number 
of incorporated nucleotides (Figure 1a). If the added nucleotide is not complimentary to the 
template nucleotide 3’ to the extension primer then DNA polymerase will not incorporate the 
dNTP and PPi will not be released [13]. 
 The enzyme ATP sulfurylase converts the released PPi to adenosine triphosphate (ATP) 
by combining PPi and adenosine 5’ phosphosulfate. The amount of ATP produced is 
proportional to the amount of PPi created by DNA polymerase. The enzyme luciferase uses the 
ATP produced by ATP sulfurylase to convert luciferin to oxyluciferin, which generates photons 
of light.  The amount of light produced by luciferase is directly proportional to the amount of 
ATP produced.  The light produced is detected with a charged coupled device (CCD) camera and 
is depicted as a peak in the pyrogram (Figure 1b).  The height of the peak is proportional to the 
amount of light produced and therefore proportional to the number of nucleotides 
incorporated[13]. 
 While the enzyme cascade producing the luciferase-catalyzed light is in progress, apyrase 
is continuously degrading any ATP or unincorporated dNTPs.  After a few seconds, all the ATP 
and dNTPs are degraded and the reaction is reset for the addition of the next nucleotide.  Due to 
the dNTPs being added in a known sequence one at a time, the created pyrogram is 
representative of the complimentary strand of the PCR amplified DNA template (Figure 1c) [13].   
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 Since sequencing is the preferred method of SNP evaluation (in terms of assuring 
accurate allele calls) pyrosequencing was evaluated to determine if it can stand up to some of the 
challenges required for Y-chromosome forensic use. Special attention was placed on the  
handling of minimal amounts of starting sample, multiple DNA sources, and mixtures of male 
DNA in overwhelming amounts of female DNA.  
It is crucial for any DNA based technology to be able to handle minimal amounts of 
starting DNA, since DNA evidence is routinely found in limited quantities. The ability to handle 
multiple DNA sources is required since all possible sources of DNA can be found and must be 
able to be used for analysis in forensic science. Male female DNA mixtures are commonly found 
in sexual assault (semen or saliva deposited in or on the female victim) and can also be found in 
other assaults when blood and other body fluids are deposited onto one another. In cases like 
these, especially in sexual assault, the female portion of the mixture can greatly overwhelm the 
male portion of the mixture.  Therefore in traditional autosomal analysis of sexual assaults the 
male/female mixtures are divided into a male, sperm fraction, and a female, epithelial fraction 
for analysis.  This can be problematic, since sample containing little male DNA can be routinely 
lost during the differential extraction procedure to separate the male and female DNA.  Y 
chromosome analysis eliminates this problem since females do not have a Y chromosome, the 
samples can be analyzed without separating or losing the male DNA.   
In order to minimize the amount of starting DNA required for analysis, limit the number 
of biotinylated templates in the pyrosequencing mixture, maximize our haplogroup diversity, all 
while maintaining proper Y-chromosome SNP allele calling a nested PCR system was 
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developed. This system amplifies 13 Y-chromosome SNP loci, approximately 300 – 500 base 
pairs in size in the first of two rounds of amplification.  The second round of amplification takes 
one to three of the starting 13 loci and amplifies them using the biotinylated primers necessary 
for Pyrosequencing (amplicons approximately 100 - 300 base pairs in size). This second 
biotinylated amplified product is then used for pyrosequencing the 13 Y-chromosome loci in 
three multiplexes (PMP1, PMP2, PMP3) and five singleplexes (M3, M74, M172, M24, and P25) 
















Figure 1. Priciples of Pyrosequencing.  A) dNTP is incorporated onto extending sequencing 
primer, causing release of pyrophosphate B) Sulfurylase convert pyrophosphate to ATP, 
Luciferase converts ATP to light, and light is detected with CCD camera C) Apyrase degrades 
unincorporated dNTPs and unused ATP to reset reaction and allow for the next nucleotide to be 
added while a pyrogram is being produced [13] 
8 
 
Figure 2. System Overview. Overview of Y-chromosome SNP analysis system from 
amplification of original starting DNA with 13 plex primer set to analysis of Pyrosequencing 
Multiplexes. 
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CHAPTER 2. METHODS 
2.1 Preparation of Body Fluid Stains 
Body fluids were collected from volunteers using procedures approved by the University 
of Central Florida’s Institutional Review Board.  Buccal samples were collected from donors 
using sterile swabs by swabbing the inside of the donor’s mouth.  Population samples for gene 
diversity and haplogroupings were obtained from local Orlando residents (buccal swabs), the 
Virginia Division of Forensic Science (bloodstains), and the Orange County Sheriff’s-Coroner’s 
office in Santa Ana, CA (DNA extracts). All samples were stored at -20oC until needed.   
 
2.2 DNA Isolation and Purification of Buccal Swabs, Saliva and Semen 
DNA was extracted from the buccal swabs and semen using a standard 
phenol:chloroform method [14].  Stains or swabs were cut into small pieces and placed into a 
Spin-Ease tube (Gibco-BRL, Grand Island NY).  The tubes containing buccal samples and saliva 
were incubated overnight in a 56oC water bath using 400 µl DNA Extraction Buffer (100mM 
NaCl, 10mM Tris-HCl, pH 8.0, 25mM EDTA, 0.5% SDS), and 0.1mg/mL Proteinase K.  The 
tubes containing semen samples were incubated overnight in a 56oC water bath using 400 µl 
DNA Extraction Buffer, 0.1mg/mL Proteinase K, and 40µL dithiotreitol (DTT). After the 
overnight incubation, all samples were placed into a Spin-Ease basket, the basket inserted back 
into the original tube, and the samples centrifuged at 14,000g for 5 minutes to remove the 
absorbed fluid from the swab material.  A volume of phenol/chloroform/isoamyl alcohol equal to 
10 
the volume of the crude extract was added and vigorously intermixed by shaking  The aqueous 
layer, containing the DNA, was removed. Precipitation of the DNA was accomplished by the 
addition of cold absolute ethanol (two and a half times the volume of the aqueous layer extract) 
and allowed to precipitate overnight at –20oC.  The DNA was pelleted by centrifugation, washed 
twice using 70% ethanol and re-solubilized with 100 µl of TE-4 (10 mM Tris-HCl, 0.1 mM 
EDTA, pH 7.5) overnight at 56oC.  
 
2.3 DNA Isolation and Purification of Dried Blood Samples 
The dried blood stains were incubated overnight at 56oC in 400 µl of DNA extraction 
buffer (100mM NaCl, 10 mM Tris-HCl, 25 mM EDTA, 0.5% SDS) and 0.1mg/mL Proteinase K.  
The swab pieces were placed into a spin ease basket and centrifuged at 14,000g for 5 minutes.  
An equal volume of phenol/chloroform/isoamyl alcohol was added to the crude extract.  The 
aqueous phase extracts containing the DNA were purified using Centricon 100TM concentrators 
(Millipore, Bedford, MA) according to the manufacturer’s instructions.   
 
2.4 Gel Electrophoresis 
2.4.1 DNA Quantitation Gel 
Extracted DNA was quantitated using a 1% agarose gel containing 0.01% Ethidium 
Bromide.  The quantitation gel was made by adding 30 µL of 5 mg/ml Ethidium Bromide (EtBr) 
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solution to 300 mL of 1X TAE (Tris-Acetate EDTA) Buffer.  30 mL of the TAE/EtBr solution 
was combined with 0.30 g of molecular biology grade agarose (Fisher, Suwanee, GA), and 
heated to a boil in a microwave.  The solution volume was measured to determine the quantity of 
water lost due to boiling.  Deionized water was used to bring the final volume up to the original 
30 mL.  The 30 mL TAE/EtBr/ Agarose solution was poured into a Minigel gel-casting tray 
containing two 12-tooth combs and allowed to harden at room temperature.  The remaining 270 
mL of the TAE/ EtBr solution was poured into the Minigel Electrophoresis chamber and the 
hardened gel was also placed in the Minigel electrophoresis chamber. The gel was then lifted and 
tilted to allow for any bubbles in or around the gel casting tray to be removed.  A 5 µL aliquot of 
the DNA samples to be tested were combined with 1 µL of 6X loading buffer (0.25% 
bromophenol blue, 0.25% xylene cyanol, 40% sucrose), vortexed then spun.  The upper lanes of 
the gel were loaded with 6 µL of the ten DNA standards (5ng, 15ng, 30ng, 60ng, 100ng, 125ng, 
200ng, 375ng, and 500ng per 6 µL volumes).  The lower lanes of the gel were loaded with the 6 
µL sample/loading buffer mixture.  Gels were run for 12-15 minutes at 200V.  The DNA bands 
were visualized using a UV transilluminator, and a visual record taken either with a Polaroid 
camera or the Omega 10™ photodocumentation system.  Calculating the concentration of DNA 
in each sample was made by visual comparisons to the known standards. 
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2.4.2 PCR Product Gel 
 PCR Product gels were made to the same specifications as the gels used for DNA 
Quantitation except that only 1 comb was used, located at the top of the gel.  These gels were 
then run for 25 minutes at 200 V, and visualized the same as the DNA Quantitation gels. 
 
2.5 Primers 
2.5.1 Initial PCR Primers 
 All initial PCR primers used were designed using one of two sources: Oligo 6 Primer 
Analysis Software (Lifesciences Software Resource, Long Lake, MN) or Primer3 [15].  Using 
Oligo 6, primers were selected which had the highest P.E. scores relative to the other primer 
options that produced a PCR product preferably less than 300 base pairs. Using Primer3, primers 
were selected that had minimal 3’ self-complementarity of the primer or oligo (“taken as a 
measure of its tendency to form a primer-dimer with itself”) or any self-complementarity (“taken 
as a measure of its tendency to anneal to itself or form secondary structure”) [15] which had PCR 
product sizes preferably less than 300 base pairs.   
 If the primer pairs were to be used with pyrosequencing, the final PCR product 
oligonucleotide sequence was then entered into pyrosequencing’s SNP Primer Design Software v 
1.01 [16] and analyzed for sequencing primers.  During the analysis of sequencing primers, the 
SNP Primer Design Software would determine if the PCR product template would form a hairpin 
loop with itself.  If this were the case, then alternate forward, reverse or both forward and reverse 
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primers would be redesigned using the same methods listed above.  Determining which primer 
(forward or reverse) would be labeled with the biotin was determined by examining the number 
of different options for the forward and reverse analysis, and the simplicity with which allele 
calls would be made.  For example, if five of the six possible extension primers in the forward 
direction caused primer dimmers and could not be used, then the reverse primer would be 
labeled.  If the analysis in the forward direction yielded a SNP within a homopolymer then the 
reverse primer would be labeled. 
 
2.5.2 Extension Primers 
 Extension Primers for SNaPshot were designed by taking 20 bases complimentary to 
either template, 5’ to the SNP site.  Extension primers for Pyrosequencing were designed using 
SNP Primer Design Software v 1.01.  Primers were selected based on the final score provided by 
the design software.  The SNP Primer Design Software evaluates scores based on seven criteria: 
Melting Temperature (reducing the score for melting temperatures below 50˚C), Mispriming 
Analysis (reducing the score for alternate priming sites for the sequencing primer), Duplex 
Formation Analysis (reducing the score for finding the existence of extension primer dimmers), 
Hairpin Loop Analysis (reducing the score for hairpin extension primer hairpin loops), Repeat 
Bases at SNP Analysis (reducing the score for homopolymers at the site of SNP) Primer length 
(reducing the score for primers over 18 nucleotides due to their high price) and Template Loop 
Analysis (reducing the score for oligonucleotide templates looping back onto itself).  The total 
score was calculated using a complicated arithmetic formula using all the scores from each of the 
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various scoring criteria.  The highest scoring primer with 19 or more nucleotides was selected for 
pyrosequencing analysis when many primers were acceptable.  When certain extension primers 
were needed for multiplex analysis those primers were chosen regardless of final score. 
 
2.5.3 External PCR Primers 
 External PCR primers used in nested PCR were designed using Primer3.  Primers were 
selected which had relatively low 3’ or any self-complementarity, and had as few base pairs 
between the newly designed external primer pairs and the previously designed internal PCR 
primers.  Preferentially the PCR product size would be less than 450 base pairs. 
 
2.6 PCR Conditions 
2.6.1 SNaPshot PCR Condition 
 Amplification of genomic DNA for SNaPshot analysis utilizes a 50 µL reaction 
containing: 0.5 – 3 ng of DNA, 1.6 µM forward and reverse primers, 1X PCR Buffer I (10 mM 
Tris-HCl, pH 8.3, 50 mM KCl, 1.5 mM MgCl),  1 mM dNTP, 2mg/ml BSA, and 0.5 units of 
Amplitaq Gold DNA Polymerase (Applied Biosystems, Foster City, CA).  Cycling conditions for 
amplification are: (1) 95˚C for 11 min (2) 32 cycles of 96˚C for 30 sec, 56˚C for 60 sec, and 
72˚C for 60 sec (3) 72˚C for 10 min (4) 4˚C for ∞. 
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2.6.2 Pyrosequencing PCR Conditions (Direct) 
 Amplification of genomic DNA for direct Pyrosequencing analysis utilizes a 50 µL 
standard reaction established by pyrosequencing containing: 0.5 – 2 ng of DNA, 2.0 µM forward 
and reverse primers, 1X PCR Buffer II (10 mM Tris-HCl, pH 8.3, 50 mM KCl), 2mM MgCl, 
500 µM dNTP, 2mg/ml BSA, and 0.3 units of Amplitaq Gold DNA Polymerase.  Cycling 
conditions for amplification are: (1) 95˚C for 5 min (2) 45 cycles of 95˚C for 15 sec, 50˚C for 30 
sec, and 72˚C for 15 sec (3) 72˚C for 5 min (4) 4˚C for ∞. 
 
2.6.3 Pyrosequencing PCR Conditions (Nested) 
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 Amplification of genomic DNA for Nested PCR and ultimate Pyrosequencing analysis 
utilizes two different reactions for two different methodologies (multiplex and singleplex), and 
are as follows: Single Locus Amplification for Outer Primer Sets (50 µL reaction):  0.5 – 1 ng of 
genomic DNA, 1.2 µM forward and reverse primer, 1X PCR Buffer II (10 mM Tris-HCl, pH 8.3, 
50 mM KCl), 1.5 mM MgCl, 500 µM dNTP, 2mg/ml BSA, and 0.3 units of Amplitaq Gold DNA 
Polymerase.  Single Locus Amplification Inner Primer Sets (50 µL reaction): 1 µL of outer PCR 
product, 2.0 µM forward and reverse primers, 1X PCR Buffer II (10 mM Tris-HCl, pH 8.3, 50 
mM KCl), 1.5 mM MgCl, 500 µM dNTP, 2mg/ml BSA, and 0.3 units of Amplitaq Gold DNA 
Polymerase.  Multiple Locus Amplification for Outer Primer Sets (50 µL reaction): 0.5 – 1 ng of 
genomic DNA, 1.2 µM forward and reverse primers, 1X PCR Buffer II (10 mM Tris-HCl, pH 
8.3, 50 mM KCl), 1.5 mM MgCl, 1 mM dNTP, 2mg/ml BSA, and 0.5 units of Amplitaq Gold 
DNA Polymerase.  Multiple Locus Amplification for Inner Primer Sets (25 µL reaction): 0.5 µL 
of outer PCR product, 0.48 - 8 µM forward and reverse primers, 1X PCR Buffer II (10 mM Tris-
HCl, pH 8.3, 50 mM KCl), 1.5 mM MgCl, 1 mM dNTP, 2mg/ml BSA, and 0.5 units of Amplitaq 
Gold DNA Polymerase.  Cycling conditions for all nested amplifications were: (1) 95˚C for 10 
min (2) 30 cycles of 95˚C for 30 sec, 54˚C for 60 sec, and 72˚C for 30 sec (3) 72˚C for 10 min 
(4) 4˚C for ∞.   
 
2.7 SNaPshot Sample Preparation 
 Template Preparation: 4 µL SNaPshot PCR products were combined with 2 units SAP 
(United States Biochemical, Clevland, OH) and 2 units ExoSAP-IT® (United States 
Biochemical) and incubated at 37˚C for 60 min followed by heating at 72˚C for 15 min.  
Reaction Preparation: 5 µL SNaPshot Ready Reaction Premix (Applied Biosystems), 1 µL 
Extension Primer (20 µM), 1 µL prepared template, and 3 µL deionized water were combined.  
The 10 µL Reaction mixture was then extended using a thermocycler and the following 
conditions: (1) 25 cycles of 96˚C for 10 sec, 50˚C for 5 sec, and 60˚C for 30 sec (2) 4˚C for ∞.  
Post-Extention Treatment:  The extended reaction mixture was incubated with 0.5 units of SAP 
for 15 min. at 72˚C. 
 
2.8 SNaPshot Sample Analysis 
 To a 0.5 mL 310 Genetic Analyzer tube (Applied Biosystem) 10 µL of deionized 
formamide was mixed with 1 µL of post treatment sample.  The Formamide/Sample mixture was 
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vortexed and spun before being incubated at 95˚C for 5 min.  The Formamide/Sample mixture 
was placed into an Applied Biosystem 310 Genetic Analyzer and run using the GS POP4 (1mL) 
E module with a 10 sec injection time, 15 kV electrophoresis and EP voltage, 24 min collection 
time, 60˚C plate temperature, 150 sec syringe pump time, and a 120 sec pre-injection EP time.   
 
2.9 Pyrosequencing Sample Preparation 
Procedure for template preparation was a modification from the original instrument 
procedures included with the PSQ 96MA instrument [17].  All reagents were mixed thoroughly 
and utilized at room temperature.  20 µL of Biotin labeled PCR product was placed into a 96 well 
filter plate.  24 µL of 1:5 mix of Steptavidin Sepharose beads/Binding buffer (10 mM Tris-HCl, 
2 M NaCl, 1 mM EDTA, 0.1% Tween 20) was added to the PCR product.  PCR 
product/Steptavidin Sepharose beads/Binding buffer mixture was mixed on a shaker at 
approximately 1500 rpms for a minimum of 10 minutes.  The shaken mixture was placed on a 
vacuum manifold to remove all the liquid in the filter plate, leaving the biotin labeled PCR 
product and Steptavidin beads.  50 µL of Denaturation solution (0.2 M NaOH) was added to the 
filter plate and allowed to incubate for a minimum of 60 sec.  Vacuum was applied to remove the 
denaturation solution, and the filter plate was rinsed twice with approximately 500 µL of 
Washing buffer (10 mM Tris-Acetate, pH 7.6), removing the wash buffer with vacuum between 
rinses. 50 µL of Annealing buffer (20 mM Tris-Acetate, 2 mM Mg-Acetate pH 7.6) was then 
added to the filter plate.  The Annealing buffer and Streptavidin bead/Biotin template were then 
removed from the filter plate using a micropipetor making sure to resuspend the Streptavidin 
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beads by pipeting up and down 4-5 times before removal.  The Annealing buffer/Streptavidin 
bead/Biotin template was added to a PSQ 96 Plate Low after 3 µL of 5 µM sequencing primer 
was added to the appropriate well.  The PSQ 96 Plate Low was then heated at 80˚ C for 2 
minutes using the PSQ 96 Sample Prep Thermoplate Low.  After 2 minutes the PSQ 96 Sample 
Plate Low was removed from the thermoplate, allowed to cool to room temperature and was 
placed within the PSQ 96MA instrument. 
 
2.10 Pyrosequencing Dispensation Order Design 
2.10.1 Singleplexes 
 Singleplexes (analysis of only one SNP in one reaction at one time) were designed using 
the PSQ 96MA 2.1 Software.  Using the SNP/Sequences submenu, the sequence surrounding the 
SNP of interest, corresponding to the labeled template strand of DNA, was inputted and all 
possible extension primers were selected.  When a possible extension primer is selected the PSQ 
96MA 2.1 Software provides the sequence of nucleotides to be analyzed from the end of the 
extension primer to end of the inputted data, complimentary to the template strand of DNA.  To 
produce the order of nucleotides dispensed for SNP analysis the SNP/Simplex entry submenu 
was used.  The extension primer of choice was brought into a blank entry form and a 
dispensation order was created by the PSQ 96MA 2.1 Software.  The dispensation order includes 
a blank nucleotide to begin the dispensation, the nucleotides needed for analysis (including at 
least 3 nonvariable peaks within close proximity to the SNP variable region), a blank nucleotide 
19 
following the SNP variable region, and if any homopolymers are over 8 nucleotides long then 
that nucleotide was dispensed twice to ensure all the nucleotides are incorporated.  
 
2.10.2 Multiplexes 
 Multiplexes (analysis of two or three SNPs in one reaction at one time) were designed in 
a similar manner to the Singleplexes using the PSQ 96MA 2.1 Software.  Using the 
SNP/Sequences submenu, the sequences surrounding the SNPs of interest corresponding to the 
labeled template strands of DNA were inputted and all possible extension primers were selected.  
To produce the order of nucleotides added for SNP analysis the SNP/Multiplex entry submenu 
was used.  Extension primers from up to three different SNPs could be brought into a blank entry 
form. The PSQ 96MA 2.1 Software creates a dispensation order that best fits the three sequences 
to analyze.  PSQ 96MA 2.1 Software attempts to make the first nucleotide a blank dispensation, 
then the order of nucleotide dispensation is created to analyze all of the SNPs so as to not overlap 
a variable site with a constant region from another template. The Software also attempts to 
provide at least one non variable nucleotide in close proximity to the SNP variable site for each 
template, to not have a SNP variable region as part of a homopolymer, and to provide a blank 
dispensation after each variable region.  If any of these conditions were not met, PSQ 96MA 2.1 
Software would provide a warning, and, either alternate extension primers were chosen to alter 
the sequences to be analyzed, or entirely new SNPs were selected to be combined in the 
multiplex. Figure 3 shows an example of how changing the extension primer for one of the two 
SNPs in a Duplex can alter the ability to provide unambiguous SNP determinations. Figure 3a 
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shows PMP3 using M170E(2) and M9E(4).  If these sequence primers were used with one 
another, the dispensation pattern would produce an overlap in reference sequence from M170 
and the variable region from M9.  Overlapping of variable regions can lead to uncertain allele 
calls using the computer algorithms.  To correct this problem, multiple extension primer 
combinations must be tried until the dispensation order produced non-overlapping variable 
regions.  Figure 3b shows how changing M170E(2) to M170E produces a dispensation order 
yielding non overlapping variable regions, therefore allowing for easier allele calls during 
analysis. This same approach was used in eliminating as many warnings as possible before 
analysis. In some instances, warnings were not able to be eliminated due to the existing 




Figure 3. Change in Extension Primer Choice. A) Dispensation order produced when PMP3 is 
analyzed using M170E(2) and M9E(4), leading to overlapping sequences from M170 reference 
sequence and M9 variable region (G nucleotide in highlighted region of chart). B) Dispensation 
order produced when PMP3 is analyzed using M170E and M9E(4), eliminating the overlapping 
sequences seen in (A). 
 
2.11 Pyrosequencing SNP Analysis 
 The pyrosequencing reaction takes place using the PSQ 96 SNP Reagent Cartridge filled 
with the appropriate amount of each nucleotide (50 µL + 0.22 µL x the number of dispensations 
of the nucleotide over all samples in the run), Enzyme (50 µL + 5.5 µL x the number of wells) 
and Substrate (50 µL + 5.5 µL x the number of wells). The PSQ 96MA instrument is run using 
the “instrument parameters code 0001” (reagent priming time 100 ms, nucleotide priming time 
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30 ms, enzyme pulse time 90 ms, substrate pulse time 88 ms, reagent pressure 400 mbar, 
nucleotide pulse time 8.5 ms, nucleotide pressure 650 mbar, block temperature 28˚C, block 
mixer frequency 35 Hz, and cycle time 65 s), and analyzed using Pyrosequencing 96MA SNP 
Analysis Software. 
 
2.12 Forensic Value Analysis 
2.12.1 Polymorphism/Y-specific Analysis 
 To determine if the SNP of interest was polymorphic and Y-specific, the SNP was 
examined in 18 African American individuals (2 from Orlando local residents and 16 from 
Virginia Division of Forensic Science), 20 Caucasian individuals (14 from Orlando local 
residents and 6 from Virginia Division of Forensic Science), 21 Hispanic individuals (1 Hispanic 
originating from the South East United States collected from a local Orlando resident and 20 
Hispanics originating from the South West United States collected from California) and 2 
controls (male-9948, and female-9947a).  Each individual tested was analyzed using a singleplex 
system to ensure the proper allele call.   
 
2.12.2 Various DNA Sources 
 To determine if the pyrosequencing method of analysis could handle different DNA 
sources, samples of semen, blood, saliva, and buccal swabs were extracted from the same 
individual.  Each of the samples was amplified using 1ng of sample and analyzed using 13plex 
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outer amplification, then PMP1, PMP2, PMP3 multiplex analysis and M3, M74, M172, M214, 
and P25 singlplex analysis. 
  
2.12.3 Minimal Starting DNA 
 To determine the minimal starting DNA required for analysis of the Nested Y 
Chromosome SNP system, extracted DNA at 1 ng/µL was diluted to various concentraiotions 
from 500 pg/µL to 1 pg/µL.  These samples were amplified using the outer 13-plex primers, then 
this product was utilized for the nested amplification of PMP1, PMP2, PMP3, M3, M74 M172, 
M214, and P25. These products were pyrosequenced and analyzed for the lowest amount of 
starting DNA that provided an unambiguous allele call for all 13 loci. 
 
2.12.4 Male/Female Mixture Analysis 
 To determine the power of the nested system to work in male/female mixtures, 1 ng of 
male DNA was mixed with 8.2 µg, 5.0µg, 1.0µg, 500 ng, and 100ng of female DNA.  300ng of 
female DNA was also mixed with 25pg, 10pg, 5pg, and 1pg of male DNA. These samples were 
amplified using the outer 13-plex primers, then this product was utilized for the nested 
amplification of PMP1, PMP2, PMP3, M3, M74 M172, M214, and P25. These products were 
pyrosequenced and analyzed for the lowest amount of starting DNA that provided an 
unambiguous allele call for all 13 loci. 
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CHAPTER 3. RESULTS 
3.1 Loci and Primers 
 Each loci examined was identified through one of two sources: reference information 
found in background literature searches, or examinations of listed Y chromosome SNPs in the 
dbSNP (http://www.ncbi.nlm.nih.gov/SNP) and the SNP consortium (http://snp.cshl.org) on-line 
databases. Table 2 lists all the Y chromosome loci examined with either SNaPshot or 
Pyrosequencing. Y chromosome loci were chosen based on referenced sequence variation in 
Caucasian and African American populations or their position within the Y chromosome 
Consortium’s Y haplotype tree [18] (Figure 4). Table 3 lists the PCR primers that were designed 
and shown to produce acceptable PCR products for the Y chromosome SNPs examined.  Table 4 
lists all the extension primers that were designed for use in both SNaPshot and Pyrosequencing.  
Table 5 lists the PCR primers designed and used for amplification of outer PCR products with 
nested PCR and the 13plex. 13plex loci were chosen based on polymorphism data.  All loci that 
had been evaluated for forensic value through polymorphic analysis at 13plex design initiation, 
that had been determined to be polymorphic and produced the most Y chromosome haplogroups, 
without overlapping any loci data were chosen for inclusion in the 13plex.  All primers were 






Loci Reference List 
Position (BLAST) 
Name Access # BP # SNP References 
M2 AC011302 24878 G/A [1, 5, 18-20] 
M3 AC007034 95124 G/A [1, 5, 18-23] 
M6 AC010135 153433 A/T/G/C [1, 5, 19, 20] 
M9 AC003032 15424 C/G [1, 5, 18-23] 
M11 AC009977 456 G/A [1, 5, 18-20] 
M17 AC009977 2988 G del [1, 5, 18-20, 22] 
M45 AC010889 106136 G/A [1, 5, 18, 20, 22] 
M60 AC144429 75152 T/- [1, 5, 18, 20] 
M63 AC010889 108987 A/G [1, 5, 20] 
M69 AC010889 132407 T/C [1, 5, 18, 20] 
M74 AC010889 128116 G/A [1, 5, 20] 
M75 AC010889 128526 G/A [1, 5, 18, 20] 
M89 AC010889 155662 C/T [1, 5, 18, 20, 22] 
M112 AC010889 6308 G/A [5, 20] 
M122 AC010889 3023 T/C [5, 18, 20-22] 
M123 AC010889 2935 G/A [5, 20] 
M124 AC010889 2850 C/T [5, 18, 20] 
M132 AC010889 134610 G/T [1, 5, 20] 
M166 AC010889 3043 G/A [5, 20] 
M168 AC002531 5996 T/C [1, 5, 18, 20] 
M170 AC002531 39796 C/A [1, 5, 18, 20] 
M172 AC004474 7940 T/G [1, 5, 18, 20] 
M173 AC004474 64722 A/C [1, 5, 18, 20] 
M174 AC002531 146284 T/C [1, 5, 18, 20] 
M181 AC002531 43558 C/T [1, 5] 
M182 AC002531 61080 C/T [5, 18] 
M203 AC006376 148621 G/C [1, 5] 




Name Access # BP # SNP References 
M213 AC006376 83974 C/T [1, 5] 
M214 AC006376 29148 C/T [1, 5, 18] 
M215 AC006376 25047 A/G [1, 5] 
M216 AC010877 131816 C/T [1, 5, 18] 
M217 AC010877 131585 A/C [1, 5, 18] 
P25 AC006386 26234 A/C [1, 18] 
P29 AC002992 73192 G/T [1, 18] 
PN1 AC010137 5488 G/A [5, 21] 
PN2 AC010137 4152 G/A [5, 21] 
PN3 AC010137 3906 T/C [5, 21] 
RS035 AC024236 5093 A/G [1] 
RS041 AC007274 109042 G/C [1] 
RS155 AC011745 83585 T/C [1] 
RS182 AC007274 66178 T/C [1] 
RS394 AC013412 172634 C/T [1] 
RS407 AC010889 81439 C/G [1] 
RS422 AC006376 147897 T/A [1] 
RS640 AC006040 130257 G/A [1] 
RS653 AC006376 148760 G/C [1] 
RS664 AC006991 16948 TT del [1] 
RS734 AC009235 149562 G/A [1] 
RS763 AC010977 106894 C/G [1] 
RS843 AC007678 19581 A/C [1] 
RS917 AC012077 111712 C/T [1] 
RS924 AC006158 46998 A/C [1] 
SRY10831 AC006040 64927 A/G [18, 21] 
TSC389 AC012077 111712 C/T [1] 
TSC810 AC006040 76207 T/C [1] 
 
Loci “Names” are those assigned in reference materials or the last three numbers of their ID if 
taken from internet databases. “Position (BLAST)” represents NCBI nucleotide accession 
number and the base pair position within the accession for the SNP of interest. “SNP” represents 
the mutation observed or reported in references.  
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Loci PCR Primer List 







M2 aagtccagacccaggaaggt  < acagctccccctttatcctc  162 
M3 aaacttcagacctccagggacattaa < ctgctgccagggctttcaaata  303 
M6 tgcttcccctactttgatgg  < tctgggagttgggagttagg  179 
M9 gcgctaccttacttacataac  < gtttggtgcctaaagattaga  190 
M11 cacgagcttcaaaaatgagga  > ctgggggaagcaaatactga  352 
M17 gagtttgtggttgctggttg  > cttgtttctccaggcttttca  167 
M45 ggggtgtggactttacgaac  < acagtggcaccaaaggtcatt  179 
M60 gccctgatgtggactcaacc  < gaggagcgacgtctacgaaag  235 
M63 ggctcagaccaaaaattcca  > aggtgggaagttggaggatt  175 
M69 gggtagcctgttcaaatca  > tggcatgaagcatgtaagga  244 
M74 ggaaagtctgaaaaataatca  < tcctgttagctagaaccttac  224 
M75 acttgtcaaaagccaaaaca  > agatcgcaccattgcagtc  199 
M89 gcccacagaaggatgctgct  < aggctggcacactttgggtc  134 
M112 atggaactattttattacacc  > aaagcaaaagagaactgcctc  192 
M122 tcctgcagcgaattagatt  > tcctgcagcgaattagatt  393 
M123 tcctgcagcgaattagatt  > tcctgcagcgaattagatt  393 
M124 tcctgcagcgaattagatt  > tcctgcagcgaattagatt  393 
M132 ccaaaagttgaatggtaaaacaga > cacccatacacaaaaatatctgga 200 
M166 tcctgcagcgaattagatt  > tcctgcagcgaattagatt  393 
M168 caagtaccagattaaggcact  < ccccagcttagtaattaactc  333 
M170 tgggttccagattttgcat  > tgagacacaacccacactgaa  232 
M172 tgcctctcagtatcaacaggtaaa > tcactccatgttggtttgga 179 
M173 aaagttgatgccacttttcaga  < gcagttttcccagatcctga  242 
M174 tctccgtcacagcaaaaatg  > cctggagatgcaaaaggaga  192 
M181 ggcttgggatttttctcctg  > tggaagaaacaacaatgacca  217 
M182 gcccctgtgtgtatgtgatg  > tgtgccatcacaccatcttt  207 
M203 agagtatcgccagccaaccag  < aagaaaatggcggaagg  137 
M207 gacggcatatttacatga  < ggaaggacatgcctttttct  347 
M213 ccaaaccaaggccatataaaaa  > aaatattcagaacttaaaacatctcgt 139 
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M214 taggctgattttgctgctga > gaggtgggagggttgctt 195 
M215 catcccatgaaatatacacagaaa  < ggaacaactgcgagcaaata  214 
M216 tcctgcagcgaattagatt  > tcctgcagcgaattagatt  339 
M217 tcctgcagcgaattagatt  > tcctgcagcgaattagatt  339 
P25 gtgaattatctgcctgaaacctg < gatggaccgagatacgagaca 60 
P29 gcactccaatctgctgacttaaa > aaataccagtcgtcaccctctct 196 
PN1 tcccctgctattgctagtcc  > agggtcttgagagggagagc  180 
PN2 agctccagccatcttttcct  > tgagtcccttgatgcaaatg  209 
PN3 cccaatccaatgctcctaac  > taccaagaggcaggggtaca  112 
RS035 gtgaagggtggatgggttc  < ggccatagtgtggactgctt  122 
RS041 g ttctcacttt gccagcttca < gcccaaggttctatctccagt 162 
RS155 gttcctgcatttttgggattt  < ccaaaggcaatatcttcagca  231 
RS182 tgtgagtgtaggcatgttcca < tatttccctccggttgtcatt 322 
RS394 caccattttcacaggatttgc < caacaccatcagccaaacctc 282 
RS407 ccaggtgattccctatggtg  < acttcttcgcatgcagctct  175 
RS422 aggctaaacatacacgcatca  > ggctaaaccgggtctacacca  282 
RS640 aggtttcccaaatgtctaaat  < ggtagcggatggttcgagcat  288 
RS653 aacagcggcggtagtgag  < gcagcgattgaaggcgtcttt  116 
RS664 ggtgtgtttgctttcttctcc > gtcttgctccttgccagttc 217 
RS734 ttggattgggtttagaagatgg > caaatccaactaatgccacca 157 
RS763 tcaatgttgcctacgtcctg > gccaatagcatatagcatagc 565 
RS843 tccctcatgacaccatcaaa  > aatgaaaatagctgccaagtaaaa 74 
RS917 gtacataccagtgatcattcacc < agaaagtttgagctttagactcc 321 
RS924 aggacggcagtactcagcat < tgacacccgaataaagtgga 225 
SRY10831 agtggaaatatagttggctca  > tcattcagtatctggcctctt  244 
TSC389 agaaagtttgagctttagactcc > gtacataccagtgatcattcacc 330 
TSC810 tttaacggttttaaactaagatcc  < ctatcggtaattcaacaaaac  262 
 
“F Primer” represents the nucleotide sequence for the forward primer. “R primer” represents the 
nucleotide sequence for the reverse primer.  “Biotin” points to the primer which has the Biotin 
label used for pyrosequencing: “<” indicated the forward primer carries the Biotin label, “>” 
indicates that the reverse primer carries the Biotin label. “PCR Product Size” is the size in base 
pairs of the PCR product using the listed primers.  
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Table 4 
Extension Primer List 
Primer Name Sequence Sequence to Analyze 
92R7E (’02) tgaacacaaaagacgtagaa g/a tttgtctttgctggtcatatttaac 
92R7E ('01) atatgaccagcaaagacaaa c/t ttctacgtcttttgtgttcatg 
M112E(2) aggatgcagtactgataaaa a c/t actgctttgtttttat 
M11E ctccctctctccttgtattc  taac a/g gaaaggtttagaacttgcataa 
M122E(2) attttcccctgag agc a/g tgaattagtatctcaattgct 
M123E(2) tctaggtattcaggcga tg c/t tgatatgctagttcagat 
M124E(2) gcacaaactcagtattatta aacc g/a acttccctgttccccccata  
M132E aacacaagcgtgagcatt aata t/g aaccatataaatgcattttttgaa 
M132E(2) cacaagcgtgagcattaata  t/g aaccatataaatgcattttttgaa 
M137E(2) catattgagattttgctttc ct a/g taaagcaaagttgag 
M166E(2) agcgtgaattagtatctcaa ttg c/t ttttctaccttgat 
M168E ttgttttaattcttcagcta  gc g/a caactcacctccaacacatactccac 
M170E ttacttaaaaatcattgttc  a/c tttttttcagtgtgggttgtgtc 
M170E(2) tatttacttaaaaatcattg ttc a/c tttttttcagtgtgggttgtg 
M172E acccattttgatgctt t/g acttaaaaggtcttcaattatt  
M172E(2) tcccccaaacccattttgat gctt t/g acttaaaaggtcttcaattatt  
M174E taccttctggagtgccc  t/c agtgcagaagtgaggggtgc 
M17E  aaccccaaaattcacttaaa aaa [c] cccgtaacaaccagcaacca 
M17E(2) tggttgctggttgttacggg [g] tttttttaagtgaattttgggg 
M181E caacttgatcatctttttg  a c/t tgctttaaggtagtagcttg 
M182E gcagtggttaatgtaaacaa  a c/t gtaataaattatgtggtatt  
M2E ttcattgttaacaaaagtcc a/g tgagatctgtggaggataa 
M2.2E tttatcctccacagatctca t/c ggacttttgttaacaatga 
M2.2E(2) ctttatcctccacagatctc a t/c ggacttttgttaacaatga 
M203E gggaggcgcttggtggca  tg [g] acaggtacgcacctccatca 
M207E caaaaggtattgttattctc  ttt [c] taaatttcttgcttgacttacattt 
M207E(2) aaggtattgttattctcttt [c] taaatttcttgcttgacttacattt 
M213E attacatatattaataagaagtca  c/t gtaacgagatgttttaagttctgaat 
M213E(2) attacatatattaataagaagtc a c/t gtaacgagatgttttaagttctgaat 
M214E ctttcgttcgtttatttttc t/c gttgttttcagacagtgtctca 
M215E cagctggaacagttagaaag  t/c cagtttgtcttaatgcagcaagtat 
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Primer Name Sequence Sequence to Analyze 
M216E agttatgtatacctgttgaa t g/a ttacatttctttaataaaggaattt 
M216E(3) gctagttatgtatacctgttga at g/a ttacatttctttaataaaggaattt 
M217E atttttccttctgaagagtt t/g gtgtcacccaactttttcattctc 
M3E tgggtcacctctgggac  tga c/t aattaggaagagctggtacctaa 
M3E(3) atgggtcacctctgggactg a c/t aattaggaagagctggtacctaa 
M3E ('01) ggtaccagctcttcctaatt gtc a/g gtcccagaggagaccca 
M42E tcagatttaggacacaaaag  c a/t actacataatgaaaaagagagc 
M45E gcagtgaaaaattatagata a/g gcaaaaagctccttctgagg 
M45-2E cctcagaaggagctttttgc t/c tatctataatttttcactgccaatt 
M60E agtaaccactgtgtgcc  tgat [a] cttaagtcatgcattttgaaatgt 
M63E gacacgctcaggtacctcaa  a/g gaatcctccaacttcccaccttcac 
M69E ggctgtttacactcctg  aaa c/t aaaatatatttcagcaag 
M6E gttggcttgtagttctttct  a/g/c/t ggaaaaatattattctaatttcc 
M74-2E cttaaagcaacttaaaaatg t/c accagtttttaaaataccta 
M74E taggtattttaaaaactggt a/g catttttaagttgctttaag 
M74E(2) tacttaaagcaacttaaaaa tg t/c accagtttttaaaatacc 
M75E acaattatcaaaccacatcc g/a tatatatacagagaaat 
M75E(2) aaagacaattatcaaaccac atcc g/a tatatatacagagaaat 
M89-2E actcaggcaaagtgagagat a/g agatttttgtacataacctta 
M89E aaggttatgtacaaaaatct c/t atctctcactttgcctgagt 
M9E attaaaagaaaaataaagag c/g attcaaccatcttaggccgt 
M9.2E acggcctaagatggttgaat g/c ctctttatttttcttttaat 
M9E(2) ttgccggattctaccaactta c/g gagaaataaaaagaaaatta 
M9E(3) aacggcctaagatggttgaa t g/c ctctttatttttcttttaat 
M9E(4) aagaaacggcctaagatggt tgaat g/c ctctttatttttcttttaat 
P25E tacgagacacaattctattt t/g caggcaggtttcaggcagataattca 
P29E caatctcatctaaaaatacctt ta c/a agcaacatctagtgtttg 
PN1E ttcccctttaagacaaaa  g/a gctctccctctcaagacccttg  
PN2E gaggtgcccctaggaggaga  a a/g gcattagttttattaatgctccttt  
PN3E taactctaatttacctcccc  c/t tcaagcagaggcagttt 
RS035E tctttttgcagttgaagttg ca a/g gaacccatccacccttcac 
RS035E(2) tgcagttgaagttgca a/g gaacccatccacccttcac 
RS035E(3) atctttttgcagttgaagtt gca a/g gaacccatccacccttcac 
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Primer Name Sequence Sequence to Analyze 
RS155E atatcttcagcacaaaagcc  taa t/c agagaaaaacttcaaacctaaacc 
RS182.2E tcctccccaaaccaaggta caca a/g aggtacacaggcacaggtg 
RS394.2E ctgcctccaatgttcccc ctgc a/g gcccctgccccccatacttcctgat 
RS407E caatatgcacccttgctaaa  c/g gaccaaatgagacactgc 
RS407E(2) ttggcaatatgcacccttgc taaa c/g gaccaaatgagacactgc 
RS422E cagtttataggtcaaatatc  tac t/a gcaaactcttcaccgctgtaact  
RS624.2E aatattaacagatgacaaag t/g gttctaaatgcccttgaattg 
RS636E aggtgaaccttgaaaatgtt a c/t actgtgtgaaaaagtcagatacaa 
RS640.2E ggagtgctcttgggaaaaa cta t/c attaaccagtcacagagctgatgatc 
RS653.2E gtttccatgaaatc c/g tgcgcagtgtcgctcactaccgccgctgt 
RS664E tcagatgacaaagagaaact ttactatat [tt] gggggagtaatgtttgatatt  
RS664E(2) tgacaaagagaaactttactatat  [tt] gggggagtaatgtttgatatt  
RS664E(3) acaaagagaaactttactatatt [t] gggggagtaatgtttgatatt  
RS678E acatgccttctcacttct c [ttctc] agaatgaacagaaacaaaggtat 
RS734E ctgcagggcaccaccagc c g/a ccttggtggtggcattagttggatttgg 
RS843E atgcactgttgtaaagcc  tg a/c gtattttacttggcagcta  
RS924.2E ccgaataaagtggataaaca t/g acacacacacacacacacacacaca 
SRY10831E aggtgaaccttgaaaatgtt a c/t actgtgtgaaaaagtcagataca  
SRY10831E(2) ataggtgaaccttgaaaatg tta c/t actgtgtgaaaaagtcagataca  
Sy81E ctttatcctccacagatctc a t/c ggacttttgttaacaatga 
Sy81E(2) tttatcctccacagatctca t/c ggacttttgttaacaatga 
TSC389E ctctgcaactaaaaatgaag t/c acatcctgggtgaatgatcactggtat 
TSC810.2E caactgaaaataccagtatc a/g caactttttgttcaaatcatac 
TSC810E atgatttgaacaaaaagttg t/c gatactggtattttcagaag 
TSC810E(2) gccaactgaaaataccagta tc a/g caactttttgttcaaatcat 
 
“Primer Name” represents the name given to the extension primer for identification. Sequence 
represents the sequence of the listed primer. Sequence to Analyze” represents the nucleotide 







Outer PCR Primer List for 13plex Primer Set 
Name Outer F Primer Outer R Primer 
PCR Product 
Size (bp) 
M3 aggaatcacttggctgtcactt taatcagtctcctcccagcaag 485 
M9 tctgaccctaagcaaatccaa gacggcgtttaaaacaatcg 443 
M74 tgagcagaaaaaggttttcaat gcaagttttcttgatgtgtgga 395 
M170 acagggttggctagtggatct acgaaggacacaaaacctctg 383 
M172 atgagccctctccatcagaa gcaaatagcaaaagggggta 376 
M207 aagggcaagcaaaatagcaa cgtgcagatgtatgtattcttcc 434 
M214 tggcatcttgaggttgattg tgatctcttgagtctggggttt 434 
P25 ccaaagcctagaatgaaattgtg caagacaaaggctaaagcaaaaa 369 
PN1 ggccaactccaaccaagtta ccatctgttgatgaggtcca 339 
PN2 ctcacattgtcccacctcct ggctgcatcatccatagctt 404 
RS640 ttcagctgagcactcttcca cgttcaccttgatgacagga 372 
RS843 ttactgccgaaagcttgaca ccaaccatttccatgtagcc 427 
TSC810 ggctttacgaggattagacagg accccgctaatgctaccttc 409 
 
Loci “Names” are those assigned in reference materials or by present lab if taken from internet 
databases. “Outer F Primer” represents the nucleotide sequence for the forward primer. “Outer R 
Primer” represents the nucleotide sequence for the reverse primer.  “PCR Product Size” is the 
size in base pairs of the PCR product using the listed primers. 
 
3.2 SNaPshot Analysis 
3.2.1 General 
 Y chromosome SNPs were analyzed using either SNaPshot or Pyrosequencing.  
SNaPshot analysis was performed with a single source male sample and loci analyzed in a single 
tube and therefore produced very straight forward results with a single peak at approximately 
2900-3200 data points on the time scale.  A positive result was arbitrarily defined as a single 
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peak height over 200 RFU. Figure 5 shows an example of a male sample (ME) when amplified 
showed only one amplification product. Therefore when analyzed using SNaPshot produced only 
one detectable nucleotide extension. In this case the male individual (ME) would be classified as 
having the A allele at the M2 locus using the M2E extension primer. 
 Although the allele calls using SnaPshot are very straight forward, they provide very little 
assurance as to the location of the extended nucleotide.  When a peak is observed due to the 
extension of the extension primer, it is unknown whether the extended nucleotide was added 





Figure 5. Standard SNaPshot Reaction. SNaPshot analysis using ABI 310 Genetic analyzer of 
male individual (ME) at the M2 locus using M2E extension primer showing only single 
extension of the A (green) nucleotide. 
 
3.2.2 Extension Primer Choice 
 With single base extension, there are only two options for the extension primers since the 
SNP must be adjacent to the 3’ end of the primer.  In most cases, either one of the primers will 
work adequately for SNP analysis.  Unfortunately, there will be instances that one or both of the 
possible primers are not suitable for SNaPshot single base extension due to either mispriming or 
lack of sufficient extension product. When examining the M9 locus, it was observed that the 
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M9E extension primer showed very minor or no extension products (Figure 6) with multiple 
individuals.  When examined using the same amplified product and the reverse primer M9.2E an 
extension product was always observed, but it was sometimes below the 200 RFU threshold 
(Figure 7). SNaPshot analysis was eliminated in favor of Pyrosequencing, to overcome the lack 
of flexibility found in extension primer selection and provide information about what nucleotide 
is being examined. 
 
Figure 6. M9E Extension. SNaPshot analysis using ABI 310 Genetic analyzer of male individual 




Figure 7. M9.2E Extension. SNaPshot analysis using ABI 310 Genetic analyzer of male 
individual (C1) at the M9 locus using M9.2E extension primer showing nucleotide extension of 
C (black) nucleotide below 200 RFU threshold. 
 
3.3 Amplification 
 After the designing of the initial PCR primer set, primers were amplified using male, 
female, and no DNA.  This method ensured that male amplification produced only one distinct 
PCR product of appropriate size, and the use of female or absence of DNA did not cause 
amplification.  PCR primer sets that caused multiple male products, no male products, or 
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products in the female or blank lanes were redesigned.  Loci that continued to show multiple 
male products, no male products, or products in the female or blank lanes were eliminated from 
the development process.  The following loci were removed due to female amplification: RS394, 
RS678, and RS924 (Figure 8), RS182, RS041, RS917, RS763, and RS743 (data not shown). All 
other loci which showed amplification of only one male product (at the appropriate size), and no 
female or blank DNA amplification products were eliminated from further evaluation.  Figure 9 
shows examples using M170, M216/7, and RS664 of what the proper amplification pattern 
should be with male amplification of only a single locus. 
 
Figure 8. Female Amplification Gel. 1% Agarose gel containing 0.01% EtBr run at 200V for 15 
min. Electrophoresis: run post amplification of male (ME, 9948) and female (K562) samples 




Figure 9. Male Amplification Gel. 1% Agarose gel containing 0.01% EtBr run at 200V for 12 
min. Electrophoresis: run post amplification of male (ME), female (9947a), and no DNA (Blank) 
samples using M170, M216/7 and RS664 PCR primers. 
 
3.4 Pyrosequencing Analysis 
3.4.1 Singleplex Analysis 
For singleplex (one SNP) pyrosequencing reactions, there are three possible outcomes the 
program recognizes, but because the Y chromosome is haploid the heterozygote outcome is 
eliminated in cases of single source analysis.  Therefore, the sequenced pyrogram is compared 
with two possible outcomes for SNP determination.  If the pyrogram matches exactly to one of 
the possible outcomes, the Pyrosequencing 96MA SNP Analysis Software will identify the SNP 
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and mark the well as passed (blue) (Figure 10).  If the produced pyrogram does not match 
exactly to one of the possible outcomes due to: peaks appearing in negative control blank 
nucleotides dispensations (Figure 11), ambiguous allele calling peaks (Figure 12), non reference 
peak heights (Figure 13), too large a substrate peak (Figure 14), or dispensation errors (peaks 
appearing between dispensations of nucleotide) (Figure 15) then the Pyrosequencing 96MA SNP 
Analysis Software will identify which SNP it believes the pyrogram best fits and marks the well 
as either to be hand checked (yellow) or failed (red) due to the severity of the inconsistencies 
with the expected results. These checked or failed reactions were routinely corrected with little 
effort. Peaks appearing in negative control blank dispensations were usually cased by template 
loops, primer dimmer formation, or alternate binding sites for the extension primer that were 
corrected with primer redesign. Ambiguous allele calls were usually the result of female 
amplification and therefore eliminated. Non reference peak heights were usually caused by steric 
hindrance if the SNP was located to close to the ends of the PCR product and were eliminated 
using primer redesign. Substrate peaks that were too high were eliminated by increasing the 
amount of washing buffer used in sample preparation. Dispensation errors were caused by 
clogged reagent cartridges that would dispense nucleotides into incorrect wells at incorrect times 
and was eliminated by changing to a new cartridge. If a locus continuously gave a hand check or 





Figure 10. Passed-General Pyrograms. Two different pyrograms for two different male 
individuals (C = ME, G = 9948) amplified at M9 locus and pyrosequenced with the M9E(3) 
extension primer. The C allele will appear as a double peak at the C dispensation (#4) and a 
blank peak at the G dispensation (#3), the G allele will appear as a single peak at both the G 
dispensation (#3) and the C dispensation (#4). 
 
Figure 11. Failed-Peak in Blank. Male sample (ME) amplified at RS624 and pyrosequenced 
using RS624.2E as extension primer. Failed due to expected blank dispensation at A nucleotide 
(#4) shows a peak height of approximately 3-4 RFU. 
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Figure 12. Failed-Ambiguous Allele Call.  Male sample (ME) amplified at RS743 locus and 
pyrosequenced with RS743E extension primer.  Ambiguous allele call due to peak in both the G 
nucleotide (#3) and the A nucleotide (#4), when theoretical outcomes predict one or the other. 
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Figure 13. Failed-Non Reference Pattern.  Male sample (C1) amplified at the M214 locus and 
pyrosequenced using the M214E extension primer.  Pattern does not match reference at T 
nucleotide (#8) which should be approximately twice as high as T nucleotide (#6), and at C 
nucleotide (#9) which should be approximately the same height as G nucleotide (#7). 
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Figure 14. Failed-Substrate Peak Too High. Male Sample (C1) amplified at M9 locus and 
pyrosequenced using M9E (3) extension primer.  Substrate peak is so high that the rest of the 
pattern is lost. 
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Figure 15. Failed-Dispensation Error.  Male Sample (576) amplified at M216/7 locus and 
pyrosequenced with M216E(3) extension primer.  Dispensation error occurred when some T 
nucleotide was inadvertently added to this reaction well (most likely when dispensing adjacent 
wells) between the C nucleotide (#6) and the T nucleotide (#7) causing a peak when no 
nucleotide should have been dispensed. 
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3.4.2 Multiplex Analysis 
 Pyrosequencing Multiplexes analyze two or three SNPs within the same reaction vessel 
in a single nucleotide disposition pattern.  The original intention for the Y chromosome SNP 
muliplex analysis system was to amplify up to 50 SNP in one large volume PCR reaction using 
biotinylated primers, then using multiple aliquots of that PCR product for pyrosequencing. 
Amplifying more than three loci in a single reaction lead to problems with high background 
peaks, nonreference sequences, and peak height balancing due to template-template interactions. 
Figure 16 shows an attempted four loci amplification (M17/M3/RS640/ M216/7) in which the 
templates alone, when mixed in a single reaction vessel, produced a pyrogram due to binding 
between the multiple templates.  Almost all amplification products of more than three loci 
caused significant pyrograms (peak heights greater than 1.5), when only the PCR products were 
examined (in the absence of any extension primers). 
Besides just the templates interacting with one another, the extension primers would at 
times interact with templates other than those intended. Figure 17 shows an attempted Duplex 
with TSC810 and M9 using TSC810.2E and M9E(3) extension primers.  When analyzing the 
multiplex it was observed that within the TSC810 variable region (dispensation number 2) of the 
pyrogram an A signal was always observed even though the singleplex for TSC810 did not show 
this background signal.  Through examination of the DNA strands present within the reaction, a 
possible alternate binding for M9E(3) was observed (Figure 17b).  This alternate binding site not 
only accounted for the observed A signal at dispensation 2, but also the increased T peak at 
dispensation number 6 (figure 17a). The T peak at dispensation number 6 should be equivalent to 
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that of the T peak at dispensation number 11, but is routinely about 1.2 times higher at 
dispensation number 6 than dispensation number 11.  These background signals were eliminated 
by altering the extension primers or by changing which loci were examined in the same reaction, 
but due to the overall complications in having so many biotinylated templates present in the 
pyrosequencing reaction, alternate methods of multiplexing were examined. 
 
 
Figure 16. Template-Template Binding.  Male sample (C7), pyrosequenced using only the 
amplified template of the M17/M3/RS640 triplex.  Template only sample was analyzed using a 





Figure 17. Background in Multiplex. A) Male individual (ME) at TSC810/M9 Duplex using 
TSC810.2E and M9E(3) as the extension primers. Red circles indicate background signals that 
are present in repeated samples.  B) Proposed alternate binding site that leads to the 
incorporation of an A and T nucleotide in TSC810/M9 multiplex.  Black letters indicate those 
belonging to DNA strands. Red letters indicate proposed incorporated nucleotides during 
pyrosequencing. 
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The nested PCR approach allowed for amplification of numerous loci while eliminating 
the problems observed with the high number of templates, by utilizing only three biotinylated 
primer sets in the second reaction. Approximately 90 different Duplex and Triplexes PCR and 
pyrosequencing reactions were analyzed for possible use in the nested PCR approach. The 
multiplexes with promising results produced no significant background patterns caused by 
primer-primer, primer-template or template-template interactions and were designed to allow for 
non ambiguous allele calling (Figure 4).  Although designed for unambiguous allele calling, 
preferential amplification caused failed pyrosequencing reactions in approximately 98% of the 
pyrosequencing different multiplexes attempted, but was eliminated with Pyrosequencing 
Multiplexes (PMP) 1, 2, and 3. 
Preferential amplification, when present,  could be observed in both product gels (Figure 
18) and in the pyrosequencing programs (Figure 19).  Figure 18 shows preferential amplification 
at RS640/RS653 with RS640 (288 bp product) amplifying more than RS653 (116 bp product), 
and M207/RS653 with M207 (347 bp product) amplifying more than RS653 (116 bp product) 
when amplified as duplexes compared to when amplified as two different singleplexes.  Figure 
19 shows the theoretical result for the duplex (M2/M213) amplification and pyrosequencing with 
a single male individual (C1 - 13 plex product).  The pyrogram shows sequence analysis of the 
M2 allele, but the M213 cannot be analyzed due to an absence of signal in the M213 nucleotide 
dispensations (C or T nucleotide at dispensation 2 or 3, T nucleotide at dispensation 11, A 
nucleotide at dispensation 12, or a G nucleotide at dispensation 14). If preferential amplification 
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could not be eliminated by altering primer concentrations then that combination of loci was 
eliminated from multiplex analysis. 
 
Figure 18. Preferential Amplification Gel. 1% Agarose gel containing 0.01% EtBr run at 200V 
for 12 min. Electrophoresis: run post amplification of male (9948 13 plex PCR product) at 
various duplexes. “a” in lane name represents the duplex amplification. “c” in lane name 
represents control where each loci was amplified individually then the PCR products mixed for 




Figure 19. Preferential Amplification Pyrogram. Male individual (C1-13 plex product) amplified 
at M2/M213 and analyzed with M2.2E(2) and M213E.  Pyrogram is missing M213 sequence 




Through altering PCR primer concentrations and loci selection, three multiplexes were 
designed. This allowed for routine unambiguous sequencing of selected polymorphic loci: PMP1 
(M207/RS843/PN2), PMP2 (TSC810/PN1/RS640), and PMP3 (M9/M170).  Each one of these 
multiplexes allows for unambiguous allele calling, and amplification in a single reaction.  PMP1 
requires the multiplex PCR reaction described in chapter 2 with 8.0 µM M207 forward and 
reverse primers, 0.3 µM RS843 forward and reverse primers, and 0.325 µM PN2 forward and 
reverse primers.  Figure 20 shows the dispensation order and all possible SNP patterns for single 
source male individuals when M207E(2), PN2E, and RS843E are used as extension primers.  
PMP2 uses the multiplex PCR reaction with 1.6 µM PN1 forward and reverse primers, 2.8 µM 
TSC810 forward and reverse primers, and 2.0 µM RS640 forward and reverse primers.  Figure 
21 shows the dispensation order and all possible SNP patterns for single source male individuals 
when TSC810E(2), PN1E, and RS640E are used as extension primers.  PMPs uses the multiplex 
PCR reaction with 2.0 µM M9 forward and reverse primers, and 2.0 µM M170 forward and 
reverse primers.  Figure 22 shows the dispensation order and all possible SNP patterns for single 
source male individuals when M170E and M9E(4) are used as extension primers. 
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Figure 20. PMP1 Outcomes. Sequences to analyze are those when M207E(2), RS843E, and 
PN2E are used for analysis. Eight possible outcomes are possible.  The PSQ96MA Software uses 
blue to reference the M207 sequence, red to indicate the RS843 sequence, and green to reference 
the PN2 sequence. Pyrogram is from single male source (9948) showing a C allele at M207, G 




Figure 21. PMP2 Outcomes. Sequences to analyze are those when TSC810E(2), PN1E, and 
RS640E are used for analysis. Eight possible outcomes use blue to reference RS640 sequence, 
red to indicate PN1 sequence, and green to reference TSC810 sequence. Pyrogram is from single 




Figure 22. PMP3 Outcomes. Sequences to analyze are those when M170E and M9E(4)  are used 
for analysis. Four possible outcomes use blue to reference M170 sequence and red to indicate 
M9 sequence. Pyrogram is from single male source (C7) showing a C allele at M170 and a C 
allele at M9. 
 
3.5 Forensic Value Analysis 
3.5.1 Loci Sequencing 
In all, 50 Y chromosome loci were suitable for male specific amplification and were able 
to be analyzed using pyrosequencing. All 50 loci were sequenced in 60 different individuals to 
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determine rate of polymorphism.  Individuals tested belonged to three different ethnicities, 
Caucasians (n = 20), African Americans (n = 18), Hispanics (n = 21), and one control (9948).  
Caucasian samples ME and C1 – C13, African American samples B1 and B2 and, the Hispanic 
sample H1 were collected with buccal swabs. Caucasian samples 174-179 and African American 
samples 181-196 were donated as dried blood stains. Hispanic samples 570-589 were contributed 
as dried down DNA extracts.  These samples were amplified at all 50 loci, individually and 
examined using singleplex pyrosequencing so as to determine each individual’s haplotype 
without ambiguity and determine the exact number of alleles observed for each locus with the 60 
examined individuals. Table 6 lists the 50 loci examined and the alleles present for each at all 60 
individuals. 
3.5.2 Loci Allele Distribution 
 The 50 loci were analyzed across all 60 individuals to determine the rate of 
polymorphism observed.  The loci fell into four distinct classes: highly polymorphic (major 
allele observed in 50% to 95% of the individuals) slightly polymorphic (major allele observed in 
95% to 99% of the individuals), and non polymorphic (major allele observed in all individuals). 
Twenty highly polymorphic loci were observed: M207, RS407, M173, RS843, M45, M74, 
RS035, TSC810, P25, M9, M89, M213, RS640, RS653, RS422, PN2, P29, M2, PN1, and M170. 
Twelve slightly polymorphic loci were observed: M3, M17, M60, M69, M124, M168, M72, 
M181, M182, M214, RS155, and SRY10831. Eighteen non polymorphic loci were observed: 
M6, M11, M42, M63, M75, M112, M122, M123, M132, M166, M174, M203, M215, M216, 
M217, PN3, RS664, and 92R7.  
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 The polymorphic loci belong in ten distinct groups. Loci within the same group have 
major and minor alleles that have an appearance of being genetically linked in this data set.  For 
instance, any individual who has the deletion at M207 also has a G allele at RS407. Conversely, 
any individual that has the C allele at M207 also has the C allele at RS407. Table 7 lists the 10 
different groups, in which the loci are grouped together, their observed major allele combination, 
and their major allele frequency for all 59 individuals (9948, male control, was excluded in allele 
frequency calculations).   
The 12 slightly polymorphic loci (M3, M17, M60, M69, M124, M168, M72, M181, 
M182, M214, RS155, and SRY10831) were all similar in that the minor allele was found in only 
one of the 59 individuals and controls examined.  The individual minor alleles were observed in 
7 different individuals: C3 (M124), C5 (M17 and M168), 176 (M172), 185 (M182, and M181), 
582 (M3), 587 (M69), and 589 (M214, RS155). The 18 non-polymorphic loci exhibited the same 
major allele in all individuals and controls examined. 
A closer look at each highly polymorphic locus group and their allele distribution shows 
significant racial differences.  For 9 of the 10 highly polymorphic locus groups (groups 1 – 9) the 
major allele in the Caucasian population is the minor allele in the African American population 
and vice versa. The Hispanic racial distribution does not show a preference for associating with 
either the African American or Caucasian racial groups. 
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Table 6 



























































181 African American C C G A T T A A G T A C C T G A G T A G C T
182 African American del G T C C C G G C C G T G A A C A C A G C T
183 African American C C G A T T A A G T A C C T G A G T A G C T
184 African American del G T C C C G G C C G T G A A C A C A G C T
185 African American del G T C C C G G C C G T C T G A G T A G T C
186 African American del G T C C C G G C C G T G A A C A C A G C T
187 African American del G T C C C G G C C G T G A A C A C A G C T
188 African American del G T C C C G G C C G T G A A C A C A G C T
189 African American del G T C C C G G C C G T G A A C A C A G C T
190 African American del G T C C C G G C C G T G A A C A C A G C T
191 African American del G T C C C G G C T A C C T G A G T A G C T
192 African American del G T C C C G G C C G T G A A C A C A G C T
193 African American C C G A T T A A G T A C C T G A G T A G C T
194 African American del G T C C C G G C C G T G A A C A C A G C T
195 African American del G T C C C G G C C G T G A A C A C A G C T
196 African American del G T C C C G G C C G T G A A C A C A G C T
B1 African American del G T C C C G G C C G T G A A C A C A G C T
B2 African American del G T C C C G G C C G T G A A C A C A G C T
C1 Caucasian C C G A T T A A G T A C C T G A G T A G C T
C2 Caucasian C C G A T T A A G T A C C T G A G T A G C T
C3 Caucasian C C T C T T G A G T A C C T G A G T A G C T
C4 Caucasian C C G A T T A A G T A C C T G A G T A G C T
C5 Caucasian C C G A T T G A G T A C C T G A G T A T C T
C6 Caucasian C C G A T T A A G T A C C T G A G T A G C T
C7 Caucasian del G T C C C G G C T A C C T G A G T C G C T
C8 Caucasian C C G A T T A A G T A C C T G A G T A G C T
C9 Caucasian C C G A T T A A G T A C C T G A G T A G C T
C10 Caucasian C C G A T T A A G T A C C T G A G T A G C T
C11 Caucasian C C G A T T A A G T A C C T G A G T A G C T
C12 Caucasian del G T C C C G G C T A C C T G A G T A G C T














































































181 C A T C G T T del T C G G T C T T A C C G T G T G T G T/GG
182 C A T C G T T del T C G G T C T T A C C G T G T G T G G
183 C A T C G T T del T C G G T C T T A C C G T G T G T G G
184 C A T C G T T del T C G G T C T T A C C G T G T G T G G
185 C G T C G T T A T C G G T C T T A C C G T G T G T G G
186 C A T C G T T del T C G G T C T T A C C G T G T G T G G
187 C A T C G T T del T C G G T C T T A C C G T G T G T G G
188 C A T C G T T del T C G G T C T T A C C G T G T G T G G
189 C A T C G T T del T C G G T C T T A C C G T G T G T G G
190 C A T C G T T del T C G G T C T T A C C G T G T G T G G
191 C A T C G T T del T C G G T C T T A C C G T G T G T G G
192 C A T C G T T del T C G G T C T T A C C G T G T G T G G
193 C A T C G T T del T C G G T C T T A C C G T G T G T G T/GG
194 C A T C G T T del T C G G T C T T A C C G T G T G T G G
195 C A T C G T T del T C G G T C T T A C C G T G T G T G G
196 C A T C G T T del T C G G T C T T A C C G T G T G T G G
B1 C A T C G T T del T C G G T C T T A C C G T G T G T G G
B2 C A T C G T T del T C G G T C T T A C C G T G T G T G G
C1 C A T C G T T del T C G G T C T T A C C G T G T G T G T/GG
C2 C A T C G T T del T C G G T C T T A C C G T G T G T G T/GG
C3 C A T C A T T del T C G G T C T T A C C G T G T G T G G
C4 C A T C G T T del T C G G T C T T A C C G T G T G T G T/GG
C5 T A T C G T T del T C G G T C T T A C C G T G T G T G G
C6 C A T C G T T del T C G G T C T T A C C G T G T G T G T/GG
C7 C A T C G T T del T C G G T C T T A C C G T G T G T G G
C8 C A T C G T T del T C G G T C T T A C C G T G T G T G T/GG
C9 C A T C G T T del T C G G T C T T A C C G T G T G T G T/GG
C10 C A T C G T T del T C G G T C T T A C C G T G T G T G T/GG
C11 C A T C G T T del T C G G T C T T A C C G T G T G T G T/GG
C12 C A T C G T T del T C G G T C T T A C C G T G T G T G G































































174 Caucasian C C G A T T A A G T A C C T G A G T A G C T
175 Caucasian C C G A T T A A G T A C C T G A G T A G C T
176 Caucasian del G T C C C G G C T A C C T G A G T A G C T
177 Caucasian del G T C C C G G C T A C C T G A G T C G C T
178 Caucasian C C G A T T A A G T A C C T G A G T A G C T
179 Caucasian C C G A T T A A G T A C C T G A G T A G C T
ME Caucasian del G T C C C G G C T A C C T G A G T C G C T
570 SW Hispanic C C G A T T A A G T A C C T G A G T A G C T
571 SW Hispanic C C G A T T A A G T A C C T G A G T A G C T
572 SW Hispanic C C G A T T A A G T A C C T G A G T A G C T
573 SW Hispanic C C G A T T A A G T A C C T G A G T A G C T
574 SW Hispanic C C G A T T A A G T A C C T G A G T A G C T
575 SW Hispanic C C G A T T A A G T A C C T G A G T A G C T
576 SW Hispanic del G T C C C G G C T A C C T G A G T C G C T
577 SW Hispanic del G T C C C G G G T A C C T G A G T A G C T
578 SW Hispanic C C G A T T A A G T A C C T G A G T A G C T
579 SW Hispanic del G T C T T G A G T A C C T G A G T A G C T
580 SW Hispanic C C G A T T A A G T A C C T G A G T A G C T
581 SW Hispanic C C G A T T A A G T A C C T G A G T A G C T
582 SW Hispanic del G T C T T G A G T A C C T G A G T A G C T
583 SW Hispanic C C G A T T A A G T A C C T G A G T A G C T
584 SW Hispanic del G T C C C G G C C G T G A A C A C A G C T
585 SW Hispanic del G T C C C G G C T A C C T G A G T C G C T
586 SW Hispanic del G T C C C G G C T A C C T G A G T C G C T
587 SW Hispanic del G T C C C G G C C G T G A A C G T A G C T
588 SW Hispanic del G T C T T G A G T A C C T G A G T A G C T
589 SW Hispanic del G T C C C G G G T A C C T G A G T A G C T
H1 SE Hispanic C C G A T T A A G T A C C T G A G T A G C T













































































174 C A T C G T T del T C G G T C T T A C C G T G T G T G T/GG
175 C A T C G T T del T C G G T C T T A C C G T G T G T G T/GG
176 C A T C G G T del T C G G T C T T A C C G T G T G T G G
177 C A T C G T T del T C G G T C T T A C C G T G T G T G G
178 C A T C G T T del T C G G T C T T A C C G T G T G T G T/GG
179 C A T C G T T del T C G G T C T T A C C G T G T G T G T/GG
ME C A T C G T T del T C G G T C T T A C C G T G T G T G G
570 C A T C G T T del T C G G T C T T A C C G T G T G T G T/GG
571 C A T C G T T del T C G G T C T T A C C G T G T G T G T/GG
572 C A T C G T T del T C G G T C T T A C C G T G T G T G T/GG
573 C A T C G T T del T C G G T C T T A C C G T G T G T G G
574 C A T C G T T del T C G G T C T T A C C G T G T G T G T/GG
575 C A T C G T T del T C G G T C T T A C C G T G T G T G T/GG
576 C A T C G T T del T C G G T C T T A C C G T G T G T G G
577 C A T C G T T del T C G G T C T T A C C G T G T G T G G
578 C A T C G T T del T C G G T C T T A C C G T G T G T G G
579 C A T C G T T del T C G G T C T T A C C G T G T G T G G
580 C A T C G T T del T C G G T C T T A C C G T G T G T G T/GG
581 C A T C G T T del T C G G T C T T A C C G T G T G T G T/GG
582 C A T T G T T del T C G G T C T T A C C G T G T G T G G
583 C A T C G T T del T C G G T C T T A C C G T G T G T G T/GG
584 C A T C G T T del T C G G T C T T A C C G T G T G T G G
585 C A T C G T T del T C G G T C T T A C C G T G T G T G G
586 C A T C G T T del T C G G T C T T A C C G T G T G T G G
587 C A C C G T T del T C G G T C T T A C C G T G T G T G G
588 C A T C G T T del T C G G T C T T A C C G T G T G T G G
589 C A T C G T C del C C G G T C T T A C C G T G T G T G G
H1 C A T C G T T del T C G G T C T T A C C G T G T G T G T/GG
9948 C A T C G T T del T C G G T C T T A C C G T G T G T G G  
 
“Sample” are local identifiers supplied by the NCFS laboratory. “Race” refers to the ethnic origin of the individual who 
supplied the sample as either “Caucasian”, “African American”, or “Hispanic”. Alleles A,G,T,C are those observed using 
pyrosequencing and would be complimentary to the template sequence (biotin labeled PCR primer strand). “del” indicates a 
deletion of the expected nucleotide at that examined position. 
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Table 7 
Polymorphic Loci Groups 






1 M207, RS407 del, G 51% 
2 M173, RS843 T, G 53% 
3 M45, M74, RS035 T, T, A 54% 
4 TSC810 G 54% 
5 M9 G 58% 
6 P25 G 59% 
7 M89, M213, RS640 A, C, T 73% 
8 RS653, RS422, PN2, P29 C, T, G, A 75% 
9 M2, PN1 T, G 76% 
10 M170 A 90% 
 
“Observed Major Allele Combination” is the alleles in order of listed loci that appear most 
frequently in the examined population and segregate together within a group. “Major Allele” is 
the percentage of examined individuals who posses the major allele combination. 
  
This finding correlates with the fact that Y chromosome SNPs are currently being 
employed to differentiate between various ethnic geographic origins similar to the Caucasian, 
African American, and Hispanic populations used.  It also provides evidence that forensic Y 
chromosome SNP analysis may be of benefit in racial determinations, when the origin of a 



















1 M207, RS407 del, G 25% 83% 48% 
2 M173, RS843 T, G 30% 83% 48% 
3 M45, M74, RS035 T, T, A 75% 17% 67% 
4 TSC810 G 35% 83% 48% 
5 M9 G 75% 17% 76% 
6 P25 G 35% 89% 57% 
7 M89, M213, RS640 A, C, T 100% 22% 90% 
8 RS653, RS422, PN2, P29 C, T, G, A 100% 28% 90% 
9 M2, PN1 T, G 100% 28% 95% 
10 M170 A 85% 100% 86% 
 
“Observed Major Allele Combination” is the alleles in order of listed loci that appear most 
frequently in the examined population and are linked within a group. n is the number of 
individuals in each racial class. 
 
3.5.3 Haplogroups 
 The 60 different individuals and controls were examined to determine the number of 
distinct haplogroups that would be created using the 20 highly polymorphic and the 12 slightly 
polymorphic loci.  Through comparative analysis, 15 different haplogroups were produced using 
the 60 different individuals and controls examined. Table 9 lists the 60 individuals and places 
them into haplogroups based on their SNP results. Each color is its own haplogroup, except for 
the individuals designated by white backgrounds, these 8 individuals have unique SNP results 
and therefore belong to their own distinct haplogroup. The largest haplogroup (shown in purple 
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in Table 9) contains 22 of the 60 individuals, or approximately 37% of the individuals examined. 
The 22 individuals came from all three of the racial groups: 11 Caucasians, 2 African Americans, 































































































C7 del G T C C C G G C T A C C T G A G T G C G C T C A T C G T T del T
576 del G T C C C G G C T A C C T G A G T G C G C T C A T C G T T del T
585 del G T C C C G G C T A C C T G A G T G C G C T C A T C G T T del T
586 del G T C C C G G C T A C C T G A G T G C G C T C A T C G T T del T
191 del G T C C C G G C T A C C T G A G T G A G C T C A T C G T T del T
C12 del G T C C C G G C T A C C T G A G T G A G C T C A T C G T T del T
177 del G T C C C G G C T A C C T G A G T T C G C T C A T C G T T del T
ME del G T C C C G G C T A C C T G A G T T C G C T C A T C G T T del T
9948 C C G A T T A A G T A C C T G A G T G A G C T C A T C G T T del T
183 C C G A T T A A G T A C C T G A G T G A G C T C A T C G T T del T
175 C C G A T T A A G T A C C T G A G T G A G C T C A T C G T T del T
179 C C G A T T A A G T A C C T G A G T G A G C T C A T C G T T del T
573 C C G A T T A A G T A C C T G A G T G A G C T C A T C G T T del T
578 C C G A T T A A G T A C C T G A G T G A G C T C A T C G T T del T
C5 C C G A T T G A G T A C C T G A G T G A T C T T A T C G T T del T
C3 C C T C T T G A G T A C C T G A G T G A G C T C A T C A T T del T
587 del G T C C C G G C C G T G A A C G T G A G C T C A C C G T T del T
185 del G T C C C G G C C G T C T G A G T G A G T C C G T C G T T A T
176 del G T C C C G G C T A C C T G A G T G A G C T C A T C G G T del T
589 del G T C C C G G G T A C C T G A G T G A G C T C A T C G T C del C
577 del G T C C C G G G T A C C T G A G T G A G C T C A T C G T T del T
582 del G T C T T G A G T A C C T G A G T G A G C T C A T T G T T del T  
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580 C C G A T T A A G T A C C T G A G T T A G C T C A T C G T T
581 C C G A T T A A G T A C C T G A G T T A G C T C A T C G T T
583 C C G A T T A A G T A C C T G A G T T A G C T C A T C G T T
C1 C C G A T T A A G T A C C T G A G T T A G C T C A T C G T T
C10 C C G A T T A A G T A C C T G A G T T A G C T C A T C G T T
C11 C C G A T T A A G T A C C T G A G T T A G C T C A T C G T T
C13 C C G A T T A A G T A C C T G A G T T A G C T C A T C G T T
C2 C C G A T T A A G T A C C T G A G T T A G C T C A T C G T T
C4 C C G A T T A A G T A C C T G A G T T A G C T C A T C G T T
C6 C C G A T T A A G T A C C T G A G T T A G C T C A T C G T T
C8 C C G A T T A A G T A C C T G A G T T A G C T C A T C G T T
C9 C C G A T T A A G T A C C T G A G T T A G C T C A T C G T T
H1 C C G A T T A A G T A C C T G A G T T A G C T C A T C G T T
579 del G T C T T G A G T A C C T G A G T G A G C T C A T C G T T
588 del G T C T T G A G T A C C T G A G T G A G C T C A T C G T T
182 del G T C C C G G C C G T G A A C A C G A G C T C A T C G T T
184 del G T C C C G G C C G T G A A C A C G A G C T C A T C G T T
186 del G T C C C G G C C G T G A A C A C G A G C T C A T C G T T
187 del G T C C C G G C C G T G A A C A C G A G C T C A T C G T T
188 del G T C C C G G C C G T G A A C A C G A G C T C A T C G T T
189 del G T C C C G G C C G T G A A C A C G A G C T C A T C G T T
190 del G T C C C G G C C G T G A A C A C G A G C T C A T C G T T
192 del G T C C C G G C C G T G A A C A C G A G C T C A T C G T T
194 del G T C C C G G C C G T G A A C A C G A G C T C A T C G T T
195 del G T C C C G G C C G T G A A C A C G A G C T C A T C G T T
196 del G T C C C G G C C G T G A A C A C G A G C T C A T C G T T
B1 del G T C C C G G C C G T G A A C A C G A G C T C A T C G T T
B2 del G T C C C G G C C G T G A A C A C G A G C T C A T C G T T
584 del G T C C C G G C C G T G A A C A C G A G C T C A T C G T T  
Each color represents one of the 15 unique haplogroups. Individuals within the same color 
belong to the same haplogroup, except for white. Individuals in white belong separately to their 
own distinct haplogroup.  
 
haplogroup (shown in orange in Table 9) contained 14 individuals (approximately 23% of the 
individuals examined) of which 13 were African American and 1 was Hispanic; no Caucasians 
were found within this haplogroup. There were 5 haplogroups that contained between 2 and 6 
individuals. 
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Through examination of the loci results and haplogroups, it was determined that not all of 
the 20 highly polymorphic and 12 slightly polymorphic loci are required to differentiate the 60 
individuals into the 15 different haplogroups.  Only 13 of the 32 loci are required: one loci from 
each of the 10 highly polymorphic loci groups, M3, M172, and M214.  Table 10 shows that 
using only these 13 loci, the 60 individuals are broken down into the same 15 haplogroups. 
 
3.5.4 Various DNA Sources 
 To determine if the 13plex pyrosequencing analysis system could be successful with most 
common DNA sources found in forensic examinations, epithelial cells, blood, semen, and saliva 
DNA from the same male individual (ME) was analyzed using the PMP1, PMP2, PMP3 
multiplexes and M3, M74, M172, M214, and P25 simplexes. All four DNA sources produced 
unambiguous pyrosequencing results for all 13 loci. Figure 23 shows the PMP1,PMP2, and 
PMP3 results for the semen sample and Figure 24 shows the M3, M74, M172, M214, and P25 























































































174 C A T A G T G G T A C T T 191 del C C G C T G G G A C T T
178 C A T A G T G G T A C T T C12 del C C G C T G G G A C T T
181 C A T A G T G G T A C T T
193 C A T A G T G G T A C T T 177 del C C G C T G G T C C T T
570 C A T A G T G G T A C T T ME del C C G C T G G T C C T T
571 C A T A G T G G T A C T T
572 C A T A G T G G T A C T T 579 del C T G G T G G G A C T T
574 C A T A G T G G T A C T T 588 del C T G G T G G G A C T T
575 C A T A G T G G T A C T T
580 C A T A G T G G T A C T T 182 del C C G C C A A G A C T T
581 C A T A G T G G T A C T T 184 del C C G C C A A G A C T T
583 C A T A G T G G T A C T T 186 del C C G C C A A G A C T T
C1 C A T A G T G G T A C T T 187 del C C G C C A A G A C T T
C10 C A T A G T G G T A C T T 188 del C C G C C A A G A C T T
C11 C A T A G T G G T A C T T 189 del C C G C C A A G A C T T
C13 C A T A G T G G T A C T T 190 del C C G C C A A G A C T T
C2 C A T A G T G G T A C T T 192 del C C G C C A A G A C T T
C4 C A T A G T G G T A C T T 194 del C C G C C A A G A C T T
C6 C A T A G T G G T A C T T 195 del C C G C C A A G A C T T
C8 C A T A G T G G T A C T T 196 del C C G C C A A G A C T T
C9 C A T A G T G G T A C T T B1 del C C G C C A A G A C T T
H1 C A T A G T G G T A C T T B2 del C C G C C A A G A C T T
584 del C C G C C A A G A C T T
9948 C A T A G T G G G A C T T
183 C A T A G T G G G A C T T C5 C A T G G T G G G A C T T
175 C A T A G T G G G A C T T C3 C C T G G T G G G A C T T
179 C A T A G T G G G A C T T 587 del C C G C C A G G A C T T
573 C A T A G T G G G A C T T 185 del C C G C C G G G A C T T
578 C A T A G T G G G A C T T 176 del C C G C T G G G A C G T
589 del C C G G T G G G A C T C
C7 del C C G C T G G G C C T T 577 del C C G G T G G G A C T T
576 del C C G C T G G G C C T T 582 del C T G G T G G G A T T T
585 del C C G C T G G G C C T T
586 del C C G C T G G G C C T T  
Each color represents one of the 15 unique haplogroups. Individuals within the same color 
belong to the same haplogroup, except for white. Individuals in white belong separately to their 





Figure 23. Semen at PMP1, PMP2, and PMP3.  Male individual ME (semen) amplified with 13-
plex outer primer set, and then analyzed using PMP1, PMP2, and PMP3 amplification and 
pyrosequencing. A) Pyrogram produced for PMP1 showing the unambiguous calling of the 
deletion at M207, the G allele at PN2, and the C allele at RS843. B) Pyrogram produced for 
PMP2 showing the unambiguous calling of the G allele at TSC810, the G allele at PN1, and the 
T allele at RS640. C) Pyrogram produced for PMP3 showing the unambiguous calling of the C 




Figure 24. Saliva at M3, M74, M172, M207, and P25. Male individual ME (saliva) amplified 
with 13-plex outer primer set, and then analyzed using M3, M74, M172, M214, and P25 simplex 
amplification and pyrosequencing. A) Pyrogram produced for M3 showing unambiguous allele 
calling of the C allele versus the alternate T allele. B) Pyrogram produced for M74 showing 
unambiguous allele calling of the C allele versus the alternate T allele. C) Pyrogram produced for 
M170 showing unambiguous allele calling of the TTT homopolymer versus the alternate TTG 
sequence. D) Pyrogram produced for M214 showing unambiguous allele calling of the T allele 
versus the alternate C allele. E) Pyrogram produced for P25 showing unambiguous allele calling 




3.5.5 Minimal Starting DNA 
 A valuable property of forensic DNA analysis systems is their ability to be examined 
with small amounts of starting DNA. The starting DNA amounts tested were: 1ng, 500pg, 100pg, 
50pg, 25pg, 10pg, 5pg, 1pg, and no starting DNA. Figure 25, shows a yield gel with the 1ng/µL 
B1 sample that was used as the starting stock to make the male DNA titrations. It was 
determined that a full profile (able to make allele calls for all 13 loci) was accomplished using all 
the titrated starting amounts of DNA, except for the 1pg and no starting DNA samples. Figure 26 
shows the PMP1, PMP2, and PMP3 pyrograms for the 5 pg of starting male DNA. Figure 27 
shows the M3, M74, M172, M214, and P25 pyrograms for the 5pg of starting male DNA Using 
the 1pg sample, PN2, TSC810, PN1, M170, and the M9 alleles were able to be determined 
unambiguously, figure 28 shows the PMP1, PMP2, and PMP3 pyrograms for the 1pg of starting 
male DNA.  All other loci, (M207, RS843, RS640, M3, M74, M172, M214, and P25) appeared 
blank.  All the samples sequenced from the no starting DNA were blank and all the alleles 
identified matched to the expected profile for the B1 individual utilized. 
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Figure 25. Dilution Yield Gel.  Yield gel showing male individual B1 at 1ng/µL as compared 
with the DNA concentration standards.  This sample was latter used for making the DNA 




Figure 26. 5pg Male at PMP1, PMP2, and PMP3.  Male individual B1 (5pg) amplified with 13-
plex outer primer set, and then analyzed using PMP1, PMP2, and PMP3 amplification and 
pyrosequencing. A) Pyrogram produced for PMP1 showing the unambiguous calling of the 
deletion at M207, the A allele at PN2, and the C allele at RS843. B) Pyrogram produced for 
PMP2 showing the unambiguous calling of the G allele at TSC810, the A allele at PN1, and the 
C allele at RS640. C) Pyrogram produced for PMP3 showing the unambiguous calling of the A 




Figure 27. 5pg Male at M3, M74, M172, M207, and P25. Male individual B1 (5pg) amplified 
with 13-plex outer primer set, and then analyzed using M3, M74, M172, M214, and P25 simplex 
amplification and pyrosequencing. A) Pyrogram produced for M3 showing unambiguous allele 
calling of the C allele versus the alternate T allele. B) Pyrogram produced for M74 showing 
unambiguous allele calling of the C allele versus the alternate T allele. C) Pyrogram produced for 
M170 showing unambiguous allele calling of the TTT homopolymer versus the alternate TTG 
sequence. D) Pyrogram produced for M214 showing unambiguous allele calling of the T allele 
versus the alternate C allele. E) Pyrogram produced for P25 showing unambiguous allele calling 





Figure 28. 1pg Male at PMP1, PMP2, and PMP3. Male individual B1 (1pg) amplified with 13-
plex outer primer set, and then analyzed using PMP1, PMP2, and PMP3 amplification and 
pyrosequencing. A) Pyrogram produced for PMP1 showing the unambiguous calling of the A 
allele at PN2, and blank patterns for M207 and RS843. B) Pyrogram produced for PMP2 
showing the unambiguous calling of the G allele at TSC810, the A allele at PN1, and a blank 
pattern for RS640. C) Pyrogram produced for PMP3 showing the unambiguous calling of the A 
allele at M170, and the C allele at M9. 
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 3.5.6 Male/Female Mixture Analysis 
 Y chromosome analysis has many applications in forensics including human 
identification (down to a family of men), paternal analysis, and missing persons, but the main 
application is when analyzing male female mixtures.  Two set of male/female mixtures were 
examined to determine how much female DNA could be present and still produce a full male 
profile with 1ng of male DNA and how much male DNA is required to get a full profile with 
300ng of contaminating female DNA.   
Ten different male female mixtures were analyzed: 1ng male (B1) with 8.2µg, 5µg, 1µg 
500ng, and 100ng female DNA (9947a) as well as 300ng 9947a mixed with 25pg, 10pg, 300ng, 
5pg, 1pg, and no male DNA (B1). It was determined that a full profile (able to make allele calls 
for all 13 loci) was accomplished using 1ng of B1 with all concentrations of 9947a (100ng – 
8.2µg), as well as with 25pg and 10pg of B1 mixed with 300ng of 9947a. Figures 29 and 30 
show the pyrograms with unambiguous allele calling produced when 10pg of male sample is 
mixed with 300ng of female sample.  Partial profiles were accomplished with 5pg (M207, 
RS843, PN2, PN1, RS640, M170, M9, M3, M74, M214, P25 were called, TSC810 and M172 
were blank) and 1pg (PN2, PN1, M170, M9, M3, and M214 were called, M207, RS843, 
TSC810, RS640, M74, M172, and P25 were blank) of B1 mixed with 300ng of 9947a.   
These results indicate that the presence of female DNA has only a minor effect in the Y 
chromosome SNP analysis system, since with 1ng of male DNA an almost unlimited amount of 
female DNA can also be present and a full profile is still obtainable (the most we were able to 
add was 8.2 µg since we had 9947a at 300ng/µL concentration and could only add 27.2µL of 
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female DNA due to limitation in sample volume allowed) and 300ng of female DNA requires the 
addition of only 5pg more DNA than without female DNA, which is roughly equivalent to the 
amount of nuclear DNA found in a single epithelial or 2 sperm cells. Another interpretation of 
the data is that a 1 to 30,000 (10pg to 300ng) mixture of male to female DNA provides a full 13 
SNP profile using the current Nested Y chromosome SNP system analyzed with pyrosequencing. 
78 
 
Figure 29. 10pg Male with 300ng Female at PMP1, PMP2, and PMP3.  Male individual B1 
(10pg) mixed with Female individual 9947a (300ng) amplified with 13-plex outer primer set, and 
then analyzed using PMP1, PMP2, and PMP3 amplification and pyrosequencing. A) Pyrogram 
produced for PMP1 showing the unambiguous calling of the deletion at M207, the A allele at 
PN2, and the C allele at RS843. B) Pyrogram produced for PMP2 showing the unambiguous 
calling of the G allele at TSC810, the A allele at PN1, and the C allele at RS640. C) Pyrogram 







Figure 30. 10pg Male with 300ng female at M3, M74, M172, M207, and P25. Male individual 
B1 (10pg) with female individual 9947a (300ng) amplified with 13-plex outer primer set, and 
then analyzed using M3, M74, M172, M214, and P25 simplex amplification and 
pyrosequencing. A) Pyrogram produced for M3 showing unambiguous allele calling of the C 
allele. B) Pyrogram produced for M74 showing unambiguous allele calling of the C allele. C) 
Pyrogram produced for M170 showing unambiguous allele calling of the TTT homopolymer. D) 
Pyrogram produced for M214 showing unambiguous allele calling of the T allele. E) Pyrogram 
produced for P25 showing unambiguous allele calling of the GGG homopolymer. 
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CHAPTER 4. CONCLUSIONS 
 
The goal was to evaluate Pyrosequencing as a technique for the analysis of Y-
chromosome SNPs for forensic applications. Using Pyrosequencing to develop a system for 
analyzing multiple Y-chromosome SNPs from multiple sources, with minimal starting DNA 
(5pg) that can be analyzed as part of a mixture of male DNA in an overwhelming amount of 
female DNA (10pg of male DNA required in a 1 to 30,000 mixture).   The system utilizes a 
nested PCR approach to amplify 13 Y-chromosome SNP loci, approximately 300 – 500 base 
pairs in size in the first round of amplification.  The second round of amplification takes one to 
three of the starting 13 loci and amplifies them using the biotinylated primers necessary for 
Pyrosequencing (amplicons approximately 100 - 300 base pairs in size). Currently, four nested 
reactions are used to get maximum diversity from the 13-plex products: PMP1, PMP2, PMP3, 
and M74. The result is a system for the analysis of multiple Y-chromosome SNPs from multiple 
sources, using minimal starting DNA.  Even in the presence of overwhelming amounts of female 
DNA, this system producing unambiguous sequenced Y-chromosome SNP haplotypes that can 
be used to distinguish a number of individuals from others who are unrelated.   
All of the data produced from pyrosequencing indicated an ability to be used in forensic 
applications.  Further work is required to determine if pyrosequencing is ideal for handling 
forensic applications, since multiple males sources, sources other than human, and degraded or 
damaged DNA was not examined.  It is very likely that pyrosequencing will not have problems 
with multiple male sources, since it can currently provide the percentage of the peaks heights 
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observed in the allele calling region in reference to the other peaks observed in the sequence.  
DNA sources other than human are not likely to be a problem since such care was taken to 
ensure that all the primers designed for this system matched only to DNA sequences found on 
the human Y-chromosome and no other sequences found within the NCBI DNA sequence 
database. In terms of degraded DNA, it is more likely that the amplification procedures, most 
likely the PCR product size, would need to be modified to accommodate for this forensic 
obstacle. Some of the current outer PCR products are fairly large, in terms of forensic 
applications (339 – 485bp) since the nested PCR approach was adopted after many of the inner 
biotinylated primer pairs were already designed and evaluated, but could easily be redesigned to 
produce smaller PCR products. 
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